posted on 2019-11-21, 18:58authored byGabriel Arteaga-Troncoso, Aide E. Chacon-Calderon, Francisco J. Martinez-Herrera, Sylvia G. Cruz-Nuñez, Marcela Lopez-Hurtado, Aurora Belmont-Gomez, Alberto M. Guzman-Grenfell, Blanca E. Farfan-Labonne, Carlos J. Neri-Méndez, Francisco Zea-Prado, Fernando M. Guerra-Infante
Non-serious adverse events reported by participants in the two treatment groups.